-
1.发明申请公开(公告)号：US20190029953A1
公开(公告)日：2019-01-31
申请号：US15562870
申请日：2016-01-12
发明人： Akira Ito , Takeshi Matsumura , Toru Gotanda , Noriko Tabayashi , Noriko Itchoda , Takashi Aoki , Uiko Kagaya
CPC分类号： A61K9/0053 , A23L33/00 , A61K9/0056 , A61K9/0058 , A61K9/20 , A61K38/212 , A61P27/16
摘要： The object of the present invention is to provide a therapeutic agent illustrating an immediate and sustained effect on chronic intractable external otitis. The present invention provide a composition, pharmaceutical composition, food and feed for preventing and/or treating chronic intractable external otitis, each comprising interferon-α (IFNα) as an active ingredient. Orally administering the composition of the present invention can provide inhibition, alleviation, treatment and prevention for chronic intractable external otitis. According to the present invention, IFNα can give a sufficient effect even when administered in a very small amount.
-
2.发明授权公开(公告)号：US10799448B2
公开(公告)日：2020-10-13
申请号：US15562870
申请日：2016-01-12
发明人： Akira Ito , Takeshi Matsumura , Toru Gotanda , Noriko Tabayashi , Noriko Itchoda , Takashi Aoki , Uiko Kagaya
摘要： The object of the present invention is to provide a therapeutic agent illustrating an immediate and sustained effect on chronic intractable external otitis. The present invention provide a composition, pharmaceutical composition, food and feed for preventing and/or treating chronic intractable external otitis, each comprising interferon-α (IFNα) as an active ingredient. Orally administering the composition of the present invention can provide inhibition, alleviation, treatment and prevention for chronic intractable external otitis. According to the present invention, IFNα can give a sufficient effect even when administered in a very small amount.
-
搜索结果
2 条记录 (耗时 0.02 秒)
